Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivativesK. Ijichi, Katsuhiro Konno, Yasuaki Hanasaki et al.|Antimicrobial Agents and Chemotherapy|1995Cited by 16